New hope for advanced throat cancer patients who have run out of options
NCT ID NCT06118333
Summary
This study is testing a new drug called BL-B01D1 for people with advanced nasopharyngeal cancer (a type of throat cancer) that has come back or spread. It is for adults whose cancer has continued to grow despite having already received several rounds of standard treatments, including immunotherapy and chemotherapy. The trial will compare the new drug against the best available chemotherapy chosen by a doctor to see which is more effective and safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.